Search Results
Guideline Updates for Extended Endocrine Therapy Decision-Making in HR+, Early-Stage Breast Cancer
Guideline Updates for Extended Endocrine Therapy Decision-Making in HR+, Early-Stage Breast Cancer
Updates in Extended Endocrine Therapy for HR+ Breast Cancer | ASCO21 & National Practice Guidelines
JADPRO Live 2023 - Standardizing Extended Endocrine Therapy Decision-Making
Harnessing the Power of Predictive Biomarkers
Utilizing the Appropriate Tool for Extended Endocrine Therapy Decision-Making: BCI vs Oncotype Dx
Breast Cancer Index, Extended Endocrine Therapy | Elizabeth Ott, PA | 2022 West Oncology APP Updates
Standardizing Extended Endocrine Therapy Recommendations
SABCS 2023 – Evolving Trends in HR+, Early-Stage Breast Cancer Diagnostics
Endocrine Therapy in Early-Stage Breast Cancer
Dr. Graff on Extended Adjuvant Therapy in Early-Stage HR+ Breast Cancer
Adjuvant Treatment for Early Stage Hormone Positive Breast Cancer: Role of Genomic Signatures